Celltrion Inc (068270) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.008x

Based on the latest financial reports, Celltrion Inc (068270) has a cash flow conversion efficiency ratio of 0.008x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩139.88 Billion ≈ $94.79 Million USD) by net assets (₩17.35 Trillion ≈ $11.76 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check 068270 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Celltrion Inc - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Celltrion Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Celltrion Inc net assets for net asset value and shareholders' equity analysis.

Celltrion Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Celltrion Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Hannover Rück SE F:HNR1	0.128x
ResMed Inc NYSE:RMD	0.085x
GE HealthCare Technologies Inc. NASDAQ:GEHC	0.027x
Fortis Inc TO:FTS	0.042x
Dover Corporation NYSE:DOV	0.026x
Raymond James Financial Inc. NYSE:RJF	0.011x
China State Construction Engineering Corp Ltd SHG:601668	0.033x
Svenska Handelsbanken AB (publ) ST:SHB-A	0.672x

Annual Cash Flow Conversion Efficiency for Celltrion Inc (2007–2025)

The table below shows the annual cash flow conversion efficiency of Celltrion Inc from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 068270 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩17.35 Trillion ≈ $11.76 Billion	₩646.05 Billion ≈ $437.82 Million	0.037x	-27.43%
2024-12-31	₩17.58 Trillion ≈ $11.91 Billion	₩901.87 Billion ≈ $611.18 Million	0.051x	+63.56%
2023-12-31	₩17.13 Trillion ≈ $11.61 Billion	₩537.16 Billion ≈ $364.02 Million	0.031x	+15424.89%
2022-12-31	₩4.27 Trillion ≈ $2.90 Billion	₩863.53 Million ≈ $585.20K	0.000x	-99.91%
2021-12-31	₩4.05 Trillion ≈ $2.74 Billion	₩911.16 Billion ≈ $617.48 Million	0.225x	+119.83%
2020-12-31	₩3.43 Trillion ≈ $2.32 Billion	₩350.75 Billion ≈ $237.70 Million	0.102x	-37.98%
2019-12-31	₩2.87 Trillion ≈ $1.95 Billion	₩473.99 Billion ≈ $321.22 Million	0.165x	+17.38%
2018-12-31	₩2.60 Trillion ≈ $1.76 Billion	₩364.79 Billion ≈ $247.21 Million	0.141x	-30.28%
2017-12-31	₩2.41 Trillion ≈ $1.63 Billion	₩485.98 Billion ≈ $329.34 Million	0.202x	+76.71%
2016-12-31	₩2.20 Trillion ≈ $1.49 Billion	₩250.89 Billion ≈ $170.02 Million	0.114x	+166.21%
2015-12-31	₩1.81 Trillion ≈ $1.23 Billion	₩77.57 Billion ≈ $52.57 Million	0.043x	-60.21%
2014-12-31	₩1.35 Trillion ≈ $913.37 Million	₩145.16 Billion ≈ $98.37 Million	0.108x	-14.59%
2013-12-31	₩1.09 Trillion ≈ $736.73 Million	₩137.08 Billion ≈ $92.90 Million	0.126x	+531.44%
2012-12-31	₩1.05 Trillion ≈ $711.67 Million	₩20.97 Billion ≈ $14.21 Million	0.020x	-71.38%
2011-12-31	₩899.55 Billion ≈ $609.61 Million	₩62.76 Billion ≈ $42.53 Million	0.070x	+61.96%
2010-12-31	₩779.89 Billion ≈ $528.52 Million	₩33.60 Billion ≈ $22.77 Million	0.043x	-72.63%
2009-12-31	₩285.67 Billion ≈ $193.60 Million	₩44.95 Billion ≈ $30.46 Million	0.157x	-26.10%
2008-12-31	₩219.72 Billion ≈ $148.90 Million	₩46.79 Billion ≈ $31.71 Million	0.213x	+117.06%
2007-12-31	₩26.59 Billion ≈ $18.02 Million	₩2.61 Billion ≈ $1.77 Million	0.098x	--

About Celltrion Inc

KO:068270 Korea Biotechnology

Market Cap

$28.76 Billion

₩42.44 Trillion KRW

Market Cap Rank

#926 Global

#19 in Korea

Share Price

₩194500.00

Change (1 day)

-0.26%

52-Week Range

₩156826.92 - ₩248500.00

All Time High

₩389079.95